Global Capsule Endoscopy Market Size, Trend & Opportunity Analysis Report, by Type (Small Bowel Capsule Endoscopy, Oesophageal Capsule Endoscopy), Application (OGIB, Crohn’s Disease), and Forecast, 2024–2035

Market Definition and Introduction

The global capsule endoscopy market, valued at USD 443.8 million in 2024, is projected to surge to USD 1,034.78 million by 2035, advancing at a robust CAGR of 8.00% during the forecast period (2024–2035). A growing demand for non-invasive diagnostics has spurred a major paradigm shift toward gastrointestinal disorders. Capsule endoscopy secures a position as an alternative in greater measure to conventional endoscopic procedures that offer complete visualisation of the small bowel and oesophagus with little to no discomfort imparted to the patient. It has arisen in modern-day medical diagnostics as a mainstay because of its ability to assess obscure gastrointestinal bleeding (OGIB), Crohn's disease, and various other GI abnormalities.

The advent of this technology, with respect to AI for image analysis and longer battery life, is driving the expansion of the industry due to the twin motivations of enhancing diagnostic accuracy and patient compliance. Furthermore, the growing incidence of chronic GI diseases and the ageing population are factors driving capsule endoscopy adoption. Regulatory approvals of innovative capsule designs and the integration of wireless connectivity to allow real-time data transmission continue to fuel market penetration.

In developing economies, high procedure costs and limited reimbursement policies may restrict market growth. Nevertheless, minimally invasive diagnostics and the increased focus on early disease detection will offer long-term demand. Strategic partnerships between medical device manufacturers and healthcare practitioners will further spur innovative developments, ensuring the market remains agile and responsive to ever-shifting clinical needs.

Recent Developments in the Industry

Medtronic Rolls Out Next-Gen PillCam SB 3 for Better Small Bowel Imaging

Medtronic debuted its PillCam SB 3 system in January 2024, which uses advanced adaptive frame rate technology for enhanced lesion detection. The latest introduction is expected to improve workload efficiency in diagnostics and increase pathology detection rates within the small bowel, further boosting the already-celebrated position Medtronic holds in the capsule endoscopy market.

Olympus Corporation Partners with World-Class Hospitals for Capsule Endoscopy Trials with AI

In June 2024, Olympus Corporation announced a partnership with various top hospitals to test the endoscopic capsule that uses AI and machine learning to detect anomalies in real time. The outcomes of the innovation are expected to reduce the time taken for diagnosis and enhance the accuracy of diagnoses, especially in patients with complicated conditions such as Crohn's disease and OGIB.

IntroMedic Gets FDA Seal of Approval for MiroCam® Oesophageal Capsule

The FDA in March 2024 gave clearance to the MiroCam® oesophageal capsule made by South Korea's IntroMedic Co., Ltd. It's intended for purposes connected with Barrett's oesophagus and the complications associated with GERD. The imaging provided by the device is ultra-high resolution, and the battery life was lengthened, setting new benchmarks in oesophageal diagnostics.

Market Dynamics

Soaring Incidence of GI Disorders Steering the Capsule Endoscopy Acceptance

The rising number of incidences of Crohn's disease, celiac disease, and OGIB constitutes the primary growth engine. The non-invasive ability of capsule endoscopy to reach difficult GI segments has rendered it an essential tool for early diagnosis and monitoring, especially in pediatric and geriatric populations.

Technological Advancements Creating Innovative Products in the Market

Integration with AI, more battery life, and high-definition imaging are providing an enormous push to capsule endoscopy. The companies are investing heavily in R&D to develop capsules with multi-spectral imaging and 3D reconstruction capabilities to enhance diagnostic accuracy and provide newer clinical applications.

High Cost and Reimbursement Challenge the Penetration of the Market

Despite the advantages, capsule endoscopy fails to gain widespread acceptance due to high costs and an inconsistent reimbursement policy in developing countries. Addressing these barriers with strategic pricing and policy advocacy will be crucial in expanding the market.

Emerging Markets Hold Untapped Potential for Growth

The Asia Pacific and Latin America are promising emergent markets supported by improved healthcare infrastructure and an ever-increasing awareness concerning minimally invasive diagnostics. Local manufacturers are stepping in with lower-cost alternatives to compete against global players.

Attractive Opportunities in the Market

AI Integration – Machine learning algorithms enhancing diagnostic accuracy and workflow efficiency
Expanded Indications – Growing use of capsule endoscopy in colorectal and oesophageal cancer screening
Telemedicine Synergy – Remote monitoring capabilities aligning with telehealth trends
Portable Readers – Compact, wireless readers facilitating point-of-care diagnostics
Biodegradable Capsules – Eco-friendly solutions reducing environmental impact
Emerging Economies – Untapped potential in Asia-Pacific and Latin American markets
Reimbursement Expansion – Advocacy for broader insurance coverage to boost adoption
Collaborative R&D – Partnerships between medtech firms and research institutions
Patient-Centric Designs – Enhanced comfort and swallowability, improving compliance
Regulatory Approvals – Faster clearances for next-gen devices, accelerating market entry

Report Segmentation

By Type: Small Bowel Capsule Endoscopy, Oesophageal Capsule Endoscopy

By Application: OGIB, Crohn’s Disease

By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)

Key Market Players

Medtronic plc, Olympus Corporation, IntroMedic Co., Ltd., Chongqing Jinshan Science & Technology Group Co., Ltd., Check-Cap Ltd., RF System lab, CapsoVision Inc., Fujifilm Holdings Corporation, AnX Robotica, Given Imaging (a Medtronic company)

Report Aspects

Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2025–2035
Report Pages: 293

Dominating Segments

Capsule Endoscopy of the Small Intestine Shows Undisputed Diagnostics Capability

The small bowel has the largest revenue share among the segments of the market because it's an important part in the diagnosis of OGIB and Crohn's disease. Innovations will greatly enhance the clinical utility of with AI-enabled lesion detection and long battery life (up to 12 hours). Rising nanoscale ionisation of advancement in the segments has also contributed to the growth because of the increasing incidence of GI disorders.

Increase in Non-Invasive Diagnostic Applications for OGIB

Among the applications, OGIB is the fastest-growing application in that it demands a reliable identification of the source of bleeding without invasive approaches. Thus, this is precisely the other reason why capsule endoscopy is considered the gold standard for OGIB diagnosis, which fails with endoscopy. There are reimbursements among the main markets, such as the US and Europe, that also induce this specific market.

Key Takeaways

Small Bowel Dominance – Preferred for comprehensive GI tract visualisation
OGIB Growth – Rising adoption due to non-invasive diagnostic advantages
AI Revolution – Machine learning transforming image analysis and reporting
Cost Barriers – High procedural expenses limit emerging market penetration
Regulatory Momentum – Faster approvals for innovative capsule designs
Asia-Pacific Boom – Expanding healthcare access drives regional demand
Eco-Friendly Trends – Biodegradable capsules gaining traction
Strategic Alliances – Collaborations accelerating R&D and market reach

Regional Insights

North America Commands Market Share with Advanced Healthcare Infrastructure

North America dominates the international market on account of hefty expenditure on healthcare, strong reimbursement policies, and early acceptance of revolutionary technologies. The U.S. has been the epicentre of advances in capsule endoscopy with regard to Medtronic and CapsoVision, leading in R&D.

Europe Training AI and Compliance Solutions

Market growth is supported in Europe by strict regulatory requirements and high rates of GI disorders. Germany and the UK are leading the way, with increasing numbers of hospitals incorporating AI-enhanced capsules into their diagnostic protocols.

Asia-Pacific Advances to Be the Fastest-Growing Region

Market growth is rapidly buoyed by fast-tracking healthcare modernisation and the rising GI disease burden in the Asia-Pacific. China and India are the last two strongholds as local players like Chongqing Jinshan work to expand production capacity to meet soaring demand.

Core Strategic Questions Answered in This Report

What is the expected growth trajectory of the capsule endoscopy market from 2024 to 2035?

The global capsule endoscopy market is projected to grow from USD 443.8 million in 2024 to USD 1,034.78 million by 2035, registering a CAGR of 8.00%. This growth is driven by technological advancements, rising GI disorder prevalence, and increasing preference for non-invasive diagnostics.

Which key factors are fuelling the growth of the capsule endoscopy market?
Rising incidence of Crohn’s disease and OGIB
Technological innovations like AI and high-definition imaging
Growing geriatric population requiring GI diagnostics
Expansion of reimbursement policies in developed markets
Increasing adoption in emerging economies

What are the primary challenges hindering the growth of the capsule endoscopy market?
High procedural and device costs
Limited reimbursement in developing regions
Competition from traditional endoscopy
Regulatory hurdles for new entrants
Patient compliance issues with capsule ingestion

Which regions currently lead the capsule endoscopy market in terms of market share?

North America holds the largest market share, followed by Europe, due to advanced healthcare infrastructure and high adoption rates. Asia-Pacific is the fastest-growing region, driven by improving healthcare access and rising disease burden.

What emerging opportunities are anticipated in the capsule endoscopy market?
AI and machine learning integration for enhanced diagnostics
Expansion into colorectal and oesophageal cancer screening
Development of biodegradable and eco-friendly capsules
Growth potential in untapped emerging markets
Strategic collaborations to accelerate innovation

Key Benefits for Stakeholders

The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
A detailed examination of market segmentation helps identify existing and emerging opportunities.
Key countries within each region are analysed based on their revenue contributions to the overall market.
The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion Show more